Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
SEED Therapeutics, Inc.
Pfizer
Masonic Cancer Center, University of Minnesota
Novartis
University of South Florida